Display search results for ** instead (458 products)

Showing 21-30 of 458

23 Jun 2021  |  Global

Frost Radar™: Artificial Intelligence-enabled Drug Discovery in the Global Pharmaceutical Industry, 2021

A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

USD 4,950.00
23 Jun 2021  |  Global

Global RNA Therapeutics:Technology Growth Opportunities

Advances in RNA Modifications, Formulation, and Stabilization to Drive Growth of RNA Therapeutics

RNA therapeutics is a rapidly expanding area of next-generation biological drugs. RNA is a versatile molecule and naturally regulates gene expression, either by upregulation or downregulation. This function is employed to design novel RNA therapeutics. The fundamentals of RNA therapeutics consists of delivering functional RNA at a target; however, ...

USD 4,950.00
13 May 2021  |  Global

Post-COVID-19 Trends Disrupt the Global Contract Research Organization (CRO) Market

Increased Focus on Patient Centricity and Diversity in Clinical Trials Provide Growth Opportunities for CROs and Technology Vendors

Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives in the contract research organization (CRO) market, covering the markets maturity, key participants, competitive landscape, and recent mergers and acquisitions. The study highlights key growth drivers and restraints, identifies initiatives by major global CROs, a...

USD 4,950.00
30 Apr 2021  |  Global

Growth Opportunities and Technology Innovations for Advanced Clinical Decision Support Platforms

Leveraging Digital Technologies for Improving Diagnostics and Clinical Decision Workflow

Clinical decision support systems (CDSS) provide actionable information for improving the decision making abilities of the health professionals. However, the traditional CDSS platforms have drawbacks such as alert fatigue, diagnostic errors, workflow disruptions that can have detrimental effect on patients health outcomes as well as healthcare prov...

USD 4,950.00
15 Apr 2021  |  Global

Advanced Micro- and Nanofluidics Revolutionizing the Point of Care Diagnostic Industry

Disruptive microfluidic technologies enabling decentralization of diagnostic tests

Microfluidics which manipulate small volumes of fluid in microchannels enable gentle manipulation of cells and molecules and precise control of experimental conditions. It allows miniaturization of bulk assays in small devices requiring small volumes of samples and reagents and integration of several components for multiplexing analysis and achievi...

USD 4,950.00
24 Dec 2020  |  Global

Emerging Neuromodulation Technologies Enabling Growth Opportunities in Mental Health Care

Breakthrough Innovations in Transcranial Electrical Stimulation, Transcranial Magnetic Stimulation, Cranial Electrotherapy Stimulation and other Non-invasive Neuromodulation Therapies Bolstering the Psychiatric Toolbox

The treatment of mental health disorders using pharmaceuticals and psychotherapy are plagued with limitations such as therapy-related adverse effects, and inability to provide effective remission. This has driven the use of neuromodulation techniques for managing these conditions. However, these traditional neuromodulation therapies have their shar...

USD 4,950.00
22 Dec 2020  |  Global

Frost Radar™: Global Endoscopy Market, 2020

A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines

Globally, the demand for minimally invasive surgeries is trending upward at a quick pace, so consequently the demand for innovative endoscopy devices used in these procedures is anticipated to surge in the mid-to-long term. Moreover, health systems will be forced to clear the backlogs of “elective surgeries” that were postponed due to the COVID...

USD 4,950.00
15 Dec 2020  |  Global

Frost Radar™: Advanced Antibodies, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

With advances in antibody-based therapies, bispecific antibodies (bsAbs) have gained momentum in the last few years after the regulatory approvals of Amgens blinatumomab (Blincyto®) and Chugais Hemlibra for Hemophilia A. The key advantage of bsAbs lies in their ability to bind two different epitopes or antigens, thereby overcoming the limitations ...

USD 4,950.00
09 Dec 2020  |  Global

Frost Radar™: Microbiome Therapeutics, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

Microbiome present in the human body has a major role to play in the overall functioning of the human body. Human microbiota consists of a diverse population of bacterial, viral and eukaryotic communities and is present on skin, nasopharynx, oral cavity, respiratory tract, gastrointestinal tract and female reproductive tract. The naturally occurri...

USD 4,950.00
04 Dec 2020  |  Global

Frost Radar™: Digital Biomarkers Through Connected Devices, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

High prevalence of complex diseases, high investments and low success rate associated with drug development, are making the health industry appeal for innovative technologies that can enhance understanding of complex diseases, contribute to the development of personalized treatments, accelerate clinical trial activities, and lower the R&D expenditu...

USD 4,950.00

USD 4,455.00 save 10 %

Showing 21-30 of 458